Mission Statement
Patient-friendly 'medicines' for people around the world.
In order to realize a sustainable society, we aim to achieve both environmental conservation and economic growth, and are promoting initiatives to continue to be a company that is needed in the future.
R&D-based company seeking "new values" for
all people wishing good health.
There are many diseases in the world, for which no effective treatments have yet been established and no drugs have been developed smoothly.
Going forward, we would also like to be of service to such diseases by further developing drugs for unmet medical needs and orphan diseases.
News
- R&DTopline Data from Treatment Period I in the Japanese Phase 2/3 Clinical Study of Paltusotine (SK-5307) in Patients with Acromegaly and Pituitary Gigantism
- R&DSanwa Kagaku Kenkyusho and Nissan Chemical Announceration to Co-develop SK-2407/SN-001 for DRPLA
- CompanySuzuken Group, EPS Holdings, and Bushu Pharmaceuticals Sign Partnership Agreement to Support the Introduction of Unapproved Drugs (Drug Loss Products) into the Japanese Market
Achieving
a sustainable
society
CSR & Sustainability
In order to realize a sustainable society, I aim to achieve both environmental conservation and economic growth, and I am promoting initiatives to ensure that we continue to be a company that is needed in the future.
About